Saltagen has built unique relationships in two major markets of the world - North America and Asia. We have carved out an investment niche by successfully focusing on early stage biotechnology startups that scale across the Pacific.
Founded in 2017, Saltagen Ventures Limited (BRM431) is a venture investment manager focused on early-stage investments. We are headquartered in Hong Kong.
Strong local partnerships and ground presence in Canada and China allow Saltagen to: I) access and set terms for exclusive deals, and II) drive valuation increase from active end-to-end deal life cycle management.